Glucocorticoids modulate TGF-β production by human fetal lung fibroblasts

Inflammation

Volumn 27, Issue 1, 2003, Pages 9-19

  Wen, Fu Qiang ^a   Kohyama, Tadashi ^a   Sköld, C Magnus ^b   Zhu, Yun Kiu ^c   Liu, Xiangde ^a   Romberger, Debra J ^a   Stoner, Julie ^d   Rennard, Stephen I ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Jincheng Hospital   (China)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

AP 1 complex; Fibroblast; Glucocorticoids; Smads; Transforming growth factor (TGF )

Indexed keywords

BUDESONIDE; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; MESSENGER RNA; PROTEIN C JUN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FETUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG FIBROBLAST; LUNG FIBROSIS; ONCOGENE C FOS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CELLS, CULTURED; DRUG ANTAGONISM; FETUS; FIBROBLASTS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; LUNG; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

EID: 0037301458     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022683010976     Document Type: Article

References (30)

1. Khalil, N. 1999. TGF-beta: from latent to active. Microbes Infect. 1:1255-1263.
2. Blobe, G. C., W. P. Schiemann, and H. F. Lodish. 2000. Role of transforming growth factor beta in human disease. N. Engl. J. Med. 342:1350-1358.
3. Roche, W. R., R. Beasley, J. H. Williams, and S. T. Holgate. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. i:520-524.
4. Jeffery, P. K., A. J. Wardlaw, F. C. Nelson, J. V. Colins, and A. B. Kay. 1989. Bronchial biopsies in asthma. Am. Rev. Respir. Dis. 140:1745-1753.
5. Rennard, S. 1997. Pathophysiological mechanisms of COPD. Eur. Respir. Rev. 7:206-210.
6. Westergren-Thorsson, G., J. Hernnas, B. Sarnstrand, A. Oldberg, D. Heinegard, and A. Malmstrom. 1993. Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. J. Clin. Invest. 92:632-637.
7. Khalil, N., R. N. O'Connor, H. W. Unruh, P. W. Warren, K. C. Flanders, A. Kemp, O. H. Bereznay, and A. H. Greenberg. 1991. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 5:155-162.
8. Myers, J. L. and A. L. Katzenstein. 1988. Epithelial necrosis and alveolar collapse in the pathogenesis of usual interstitial pneumonia. Chest. 94:1309-1311.
9. Kuhn, C. and J. A. McDonald. 1991. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Am. J. Pathol. 138:1257-1265.
10. Sayiner, A., Z. A. Aytemur, M. Cirit, and I. Unsal. 2001. Systemic glucocorticoids in severe exacerbations of COPD. Chest. 119:726-730.
11. van der Molen, T., B. Meyboom-de Jong, H. H. Mulder, and D. S. Postma. 1998. Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment. Am. J. Respir. Crit. Care Med. 158:121-125.
12. Simons, F. E. 1998. Benefits and risks of inhaled glucocorticoids in children with persistent asthma. J. Allergy Clin. Immunol. 102:S77-S84.
13. Ziesche, R., E. Hofbauer, K. Wittmann, V. Petkov and L. H. Block. 1999. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N. Eng. J. Med. 341:1264-1269.
14. Epler, G. R. 2001. Bronchiolitis obliterans organizing pneumonia. Arch. Intern. Med. 161:158-164.
15. Wen, F. Q., C. M. Skold, X. D. Liu, R. F. Ertl, Y. K. Zhu, T. Kohyama, H. Wang and S. I. Rennard. 2001. Glucocorticoids and TGF-beta1 synergize in augmenting fibroblast mediated contraction of collagen gels. Inflammation. 25:109-117.
16. Skold, C. M., X. Liu, Y. K. Zhu, T. Umino, K. Takigawa, Y. Ohkuni, R. F. Ertl, J. R. Spurzem, D. J. Romberger, R. Brattsand and S. I. Rennard. 1999. Glucocorticoids augment fibroblast mediated contraction of collagen gels by inhibition of endogenous PGE production. Proc. Assn. Am. Phys. 111:249-258.
17. Kim, S. J., P. Angel, R. Lafyatis, K. Hattori, K. Y. Kim, M. B. Spore, M. Karin and A. B. Roberts. 1990. Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol. Cell Biol. 10:1492-1497.
18. Bascom, C. C., J. R. Wolfshohl, R. J. Coffey, Jr., L. Madisen, N. R. Webb, A. R. Purchio, R. Derynck and H. L. Moses. 1989. Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2. Mol. Cell Biol. 9:5508-5515.
19. Chomczynski, P. and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
20. Kelley, J., S. Shull, J. J. Walsh, K. R. Cutroneo and M. Absher. 1993. Auto-induction of transforming growth factor-beta in human lung fibroblasts. Am. J. Respir. Cell Mol. Bio. 8:417-424.
21. Parrelli, J. M., N. Meisler and K. R. Cutroneo. 1998. Identification of a glucocorticoid response element in the human transforming growth factor beta 1 gene promoter. Int. J. Biochem. Cell Biol. 30:623-627.
22. Song, C.-Z., X. Tian and T. D. Gelehrter. 1999. Glucocorticoid receptor inhibits transforming growth factor b signaling by directly targeting the transcriptional activation function of Smad3. PNAS. 96:11776-11781.
23. Almawi, W. Y., H. N. Beyhum, A. A. Rahme and M. J. Rieder. 1996. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukoc. Biol. 60:563-572.
24. Letterio, J. J. and A. B. Roberts. 1996. Transforming growth factor-beta1-deficient mice: identification of isoform-specific activities in vivo. J. Leukoc. Biol. 59:769-774.
25. Letterio, J. J. and E. P. Bottinger. 1998. TGF-beta knockout and dominant-negative receptor transgenic mice. Miner Electrolyte Metab. 24:161-167.
26. Massague, J. 1998. TGF-beta signal transduction. Annu. Rev. Biochem. 67:753-791.
27. Foitzik, K., R. Paus, T. Doetschman and G. P. Dotto. 1999. The TGF-β2 isoform is both a required and sufficient inducer of routine hair follicle morphogenesis. Dev. Biol. 212:278-289.
28. Khalil, N., O. Bereznay, M. Sporn and A. H. Greenberg. 1989. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 170:727-737.
29. Assoian, R. K. and M. B. Sporn. 1986. Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J. Cell Biol. 102:1217-1223.
30. Seersholm, N., M. Wencker, N. Banik, K. Viskum, A. Dirksen, A. Kok-Jensen and N. Konietzko. 1997. Does alphal-anti-trypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. Eur. Respir. J. 10:2260-2263.